Clinical Trial Update: Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of topically applied AMTX-100 CF in adults with mild to moderate atopic dermatitis has completed. Results were posted in May 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AMTX-100 CF

Snippet

Sponsor: Amytrx Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-02